These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7951311)

  • 1. Are human genes risk factors for AIDS?
    Louie LG
    Nat Genet; 1994 Aug; 7(4):456-7. PubMed ID: 7951311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug allergy and atopy: lessons from AIDS].
    Polla BS
    Rev Mal Respir; 1995; 12(2):77-8. PubMed ID: 7746950
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy, HLA allogeneic challenge, and implications for AIDS etiology.
    Hoff C
    Med Hypotheses; 1999 Jul; 53(1):63-8. PubMed ID: 10499827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human genes that limit AIDS.
    O'Brien SJ; Nelson GW
    Nat Genet; 2004 Jun; 36(6):565-74. PubMed ID: 15167933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial focus of HIV infection].
    Rakhmanova AG; Prigozhina VK; Bogoiavlenskiĭ GV; Krylov AA; Makarenko GA; Fomin IuA; Chernykh MD; Smirnov AV
    Klin Med (Mosk); 1991 Jun; 69(6):100-3. PubMed ID: 1837808
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS/HIV. A STEP into darkness or light?
    Moore JP; Klasse PJ; Dolan MJ; Ahuja SK
    Science; 2008 May; 320(5877):753-5. PubMed ID: 18467578
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic diversity and progression to AIDS.
    Res Initiat Treat Action; 1999 Apr; 5(2):33. PubMed ID: 11366286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts.
    Scorza Smeraldi R; Fabio G; Lazzarin A; Eisera N; Uberti Foppa C; Moroni M; Zanussi C
    Hum Immunol; 1988 Jun; 22(2):73-9. PubMed ID: 3262099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenetic disposition in HIV infection. Consequences for transfusion medicine?].
    Kuntz BM; Wilhelm AM; Heimbach A; Brüster HT
    Beitr Infusionther Klin Ernahr; 1987; 18():17-20. PubMed ID: 3439967
    [No Abstract]   [Full Text] [Related]  

  • 11. Progression of HIV to AIDS: a protective role for HLA-B27?
    den Uyl D; van der Horst-Bruinsma IE; van Agtmael M
    AIDS Rev; 2004; 6(2):89-96. PubMed ID: 15332431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
    Brander C; Walker BD
    Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.
    Hendel H; Caillat-Zucman S; Lebuanec H; Carrington M; O'Brien S; Andrieu JM; Schächter F; Zagury D; Rappaport J; Winkler C; Nelson GW; Zagury JF
    J Immunol; 1999 Jun; 162(11):6942-6. PubMed ID: 10352317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of T cell receptor dependent activation pathways by HIV-1.
    Maitland AL; Gaulton GN
    Pathol Biol (Paris); 1993 May; 41(5):445-8. PubMed ID: 8414675
    [No Abstract]   [Full Text] [Related]  

  • 17. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction.
    Heeney J; Jonker R; Koornstra W; Dubbes R; Niphuis H; Di Rienzo AM; Gougeon ML; Montagnier L
    J Med Primatol; 1993; 22(2-3):194-200. PubMed ID: 8105093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
    Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
    J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of HLA genotype on AIDS.
    Carrington M; O'Brien SJ
    Annu Rev Med; 2003; 54():535-51. PubMed ID: 12525683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.
    Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH
    J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.